| __timestamp | Corcept Therapeutics Incorporated | Halozyme Therapeutics, Inc. |
|---|---|---|
| Wednesday, January 1, 2014 | 26551000 | 75334000 |
| Thursday, January 1, 2015 | 50286000 | 135057000 |
| Friday, January 1, 2016 | 81321000 | 146691000 |
| Sunday, January 1, 2017 | 159201000 | 316613000 |
| Monday, January 1, 2018 | 251247000 | 151862000 |
| Tuesday, January 1, 2019 | 306486000 | 195992000 |
| Wednesday, January 1, 2020 | 353874000 | 267594000 |
| Friday, January 1, 2021 | 365978000 | 443310000 |
| Saturday, January 1, 2022 | 401858000 | 660116000 |
| Sunday, January 1, 2023 | 482375000 | 829253000 |
| Monday, January 1, 2024 | 1015324000 |
Data in motion
In the dynamic world of biotechnology, revenue growth is a key indicator of success. Over the past decade, Halozyme Therapeutics, Inc. and Corcept Therapeutics Incorporated have been in a close race. Starting in 2014, Halozyme's revenue was nearly three times that of Corcept. However, Corcept has shown remarkable growth, increasing its revenue by over 1,700% by 2023. Meanwhile, Halozyme's revenue surged by approximately 1,000% during the same period. By 2023, Halozyme maintained a lead with revenues 72% higher than Corcept. This trend highlights the competitive nature of the biotech industry, where innovation and strategic partnerships drive financial performance. As both companies continue to expand their portfolios, investors and industry watchers will be keenly observing their next moves.
Amgen Inc. or Halozyme Therapeutics, Inc.: Who Leads in Yearly Revenue?
Vertex Pharmaceuticals Incorporated vs Halozyme Therapeutics, Inc.: Annual Revenue Growth Compared
Comparing Revenue Performance: Zoetis Inc. or Halozyme Therapeutics, Inc.?
Regeneron Pharmaceuticals, Inc. and Halozyme Therapeutics, Inc.: A Comprehensive Revenue Analysis
Breaking Down Revenue Trends: Dr. Reddy's Laboratories Limited vs Corcept Therapeutics Incorporated
Jazz Pharmaceuticals plc and Corcept Therapeutics Incorporated: A Comprehensive Revenue Analysis
Cost of Revenue: Key Insights for Halozyme Therapeutics, Inc. and Corcept Therapeutics Incorporated
Revenue Insights: Halozyme Therapeutics, Inc. and Ligand Pharmaceuticals Incorporated Performance Compared
Revenue Showdown: Halozyme Therapeutics, Inc. vs Geron Corporation
Revenue Insights: Grifols, S.A. and Corcept Therapeutics Incorporated Performance Compared
Revenue Insights: Corcept Therapeutics Incorporated and Veracyte, Inc. Performance Compared
Corcept Therapeutics Incorporated vs Merus N.V.: Examining Key Revenue Metrics